Catalyst Pharmaceuticals Inc (CPRX) is near the top in its industry group according to InvestorsObserver. CPRX gets an overall rating of 54. That means it scores higher than 54 percent of stocks. Catalyst Pharmaceuticals Inc gets a 87 rank in the Biotechnology industry. Biotechnology is number 113 out of 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 54 would rank higher than 54 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Catalyst Pharmaceuticals Inc Stock Today?
Catalyst Pharmaceuticals Inc (CPRX) stock is higher by 5.59% while the S&P 500 is lower by -1.69% as of 12:21 PM on Wednesday, May 12. CPRX is higher by $0.27 from the previous closing price of $4.74 on volume of 1,242,583 shares. Over the past year the S&P 500 has risen 42.22% while CPRX is higher by 9.15%. CPRX earned $0.71 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 7.09.
Click Here to get the full Stock Score Report on Catalyst Pharmaceuticals Inc (CPRX) Stock.
